Title: Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial.
Journal: Medicine 20151201
Title: Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition.
Journal: Scientific reports 20140101
Title: Nafamostat mesilate, a noncalcium compound, as an anticoagulant, induces calcium-dependent haemolysis when infused with packed erythrocytes.
Journal: Transfusion medicine (Oxford, England) 20120601
Title: [Could nafamostat or gabexate prevent the post endoscopic retrograde cholangiopancreatography pancreatitis?].
Journal: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20120301
Title: Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.
Journal: The American journal of pathology 20120101
Title: The role of nafamostat mesylate in continuous renal replacement therapy among patients at high risk of bleeding.
Journal: Renal failure 20120101
Title: Protease activity increases in plasma, peritoneal fluid, and vital organs after hemorrhagic shock in rats.
Journal: PloS one 20120101
Title: Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis.
Journal: Arthritis research & therapy 20120101
Title: Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine.
Journal: PloS one 20120101
Title: Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.
Journal: Clinical oral investigations 20111201
Title: Is high-dose nafamostat mesilate effective for the prevention of post-ERCP pancreatitis, especially in high-risk patients?
Journal: Pancreas 20111101
Title: The pharmacological profile of brain liver intestine Na+ channel: inhibition by diarylamidines and activation by fenamates.
Journal: Molecular pharmacology 20111101
Title: Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
Journal: Journal of hepato-biliary-pancreatic sciences 20110901
Title: Effect of various anticoagulant agents on large-volume leukocytapheresis using new Cellsorba CS-180S Filter.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20110801
Title: Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice.
Journal: Cancer letters 20110701
Title: Use of nafamostat mesilate as an anticoagulant during extracorporeal membrane oxygenation.
Journal: Journal of Korean medical science 20110701
Title: Nafamostat mesilate as an anticoagulant during continuous veno-venous hemodialysis: a three-year retrospective cohort study.
Journal: The International journal of artificial organs 20110701
Title: RNA interference inhibits high mobility group box 1 by lipopolysaccharide-activated murine macrophage RAW 264.7 secretion.
Journal: The Journal of surgical research 20110615
Title: Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancer.
Journal: Pancreas 20110501
Title: Nafamostat mesilate attenuates Postreperfusion Syndrome during liver transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20110501
Title: Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis.
Journal: International immunopharmacology 20110401
Title: Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized, double-blind, controlled trial.
Journal: Pancreas 20110301
Title: [Synthetic protease inhibitors for the treatment of DIC].
Journal: Rinsho byori. The Japanese journal of clinical pathology 20110201
Title: Protease inhibitor nafamostat mesilate attenuates complement activation and improves function of xenografts in a discordant lung perfusion model.
Journal: Xenotransplantation 20110101
Title: Human eosinophils exert TNF-α and granzyme A-mediated tumoricidal activity toward colon carcinoma cells.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20101215
Title: The proteinase/proteinase-activated receptor-2/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice.
Journal: Life sciences 20101120
Title: Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model.
Journal: Oncology reports 20101001
Title: The results of severe acute pancreatitis treatment with continuous regional arterial infusion of protease inhibitor and antibiotic: a randomized controlled study.
Journal: Pancreas 20100801
Title: Pretreatment with nafamostat mesilate, a kallikrein inhibitor, to decrease withdrawal response associated with rocuronium.
Journal: Journal of anesthesia 20100801
Title: Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate.
Journal: Acta dermato-venereologica 20100701
Title: Inhibition of intraluminal pancreatic enzymes with nafamostat mesilate improves clinical outcomes after hemorrhagic shock in swine.
Journal: The Journal of trauma 20100501
Title: Nafamostat mesilate is not appropriate as an anticoagulant during continuous renal replacement therapy in dogs.
Journal: The Journal of veterinary medical science 20100301
Title: Serine protease inhibitor attenuates intracerebral hemorrhage-induced brain injury and edema formation in rat.
Journal: Acta neurochirurgica. Supplement 20100101
Title: [Treatment of disseminated intravascular coagulation].
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology 20100101
Title: Anticoagulation in acute blood purification for acute renal failure in critical care.
Journal: Contributions to nephrology 20100101
Title: The modulation of TRPM7 currents by nafamostat mesilate depends directly upon extracellular concentrations of divalent cations.
Journal: Molecular brain 20100101
Title: Biological effect of anaphylatoxin C5a on the generation of anti-inflammatory substances in leukocyte adsorption.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20091201
Title: Effects of nafamostat mesilate on coagulopathy with chronic aortic dissection.
Journal: The Annals of thoracic surgery 20091001
Title: The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis.
Journal: The American journal of pathology 20090801
Title: Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
Journal: Anticancer research 20090801
Title: Brugada-like electrocardiographic pattern due to hyperkalemia.
Journal: Clinical cardiology 20090701
Title: Effect of low-molecular weight trypsin inhibitor, nafamostat mesilate, on trypsin activity using the pancreatic acinar cells.
Journal: Pancreas 20090701
Title: Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
Journal: Gastrointestinal endoscopy 20090401
Title: Refractory kaposiform hemangioendothelioma that expressed vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3: a case report.
Journal: Journal of pediatric hematology/oncology 20090301
Title: Involvement of Tryptase and Proteinase-Activated Receptor-2 in Spontaneous Itch-Associated Response in Mice With Atopy-like Dermatitis.
Journal: Journal of pharmacological sciences 20090301
Title: A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20090201
Title: Mast cells reduce survival of myenteric neurons in culture.
Journal: Neuropharmacology 20090201
Title: The new strategy of liver transplantation from marginal donors using serine protease inhibitor.
Journal: Transplantation proceedings 20090101
Title: Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis.
Journal: Journal of gastroenterology 20090101
Title: Successful treatment of Kasabach-Merritt syndrome with vincristine and diagnosis of the hemangioma using three-dimensional imaging.
Journal: Pediatric hematology and oncology 20090101
Title: Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage.
Journal: Renal failure 20090101
Title: Nafamostat prevents hypothermia and improves survival time after administration of lipopolysaccharide in a mouse surgical model.
Journal: Journal of anesthesia 20090101
Title: The mannose-binding lectin pathway is a significant contributor to reperfusion injury in the type 2 diabetic heart.
Journal: Diabetes & vascular disease research 20090101
Title: Complement inhibitor prevents disruption of sodium channel clusters in a rabbit model of Guillain-Barré syndrome.
Journal: Journal of neuroimmunology 20081215
Title: Structure of human prostasin, a target for the regulation of hypertension.
Journal: The Journal of biological chemistry 20081212
Title: An in vivo approach for globally estimating the drug flow between blood and tissue for nafamostat mesilate: the main hydrolysis site determination in human.
Journal: Biological & pharmaceutical bulletin 20081101
Title: Nafamostat mesilate, a potent serine protease inhibitor, inhibits airway eosinophilic inflammation and airway epithelial remodeling in a murine model of allergic asthma.
Journal: Journal of pharmacological sciences 20081101
Title: Management of uremic patients with heparin-induced thrombocytopenia requiring hemodialysis.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20081001
Title: Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
Journal: Journal of cardiovascular pharmacology 20080801
Title: A method for quantifying the unstable and highly polar drug nafamostat mesilate in human plasma with optimized solid-phase extraction and ESI-MS detection: more accurate evaluation for pharmacokinetic study.
Journal: Analytical and bioanalytical chemistry 20080601
Title: Tryptase activates TGFbeta in human airway smooth muscle cells via direct proteolysis.
Journal: Biochemical and biophysical research communications 20080530
Title: Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
Journal: Pancreas 20080401
Title: Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion.
Journal: American journal of physiology. Heart and circulatory physiology 20080301
Title: Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment.
Journal: Diabetes care 20080301
Title: Characteristics of gabexate mesilate-induced cell injury in porcine aorta endothelial cells.
Journal: Journal of pharmacological sciences 20080301
Title: Effects of direct haemoperfusion through fibres immobilizing polymyxin B and nafamostat mesilate on endotoxaemia in conscious Guinea-pigs.
Journal: Clinical and experimental pharmacology & physiology 20080101
Title: Pancreaticoduodenectomy for bile duct carcinoma of a patient undergoing hemodialysis.
Journal: Hepato-gastroenterology 20080101
Title: A sudden onset of diabetic ketoacidosis and acute pancreatitis after introduction of mizoribine therapy in a patient with rheumatoid arthritis.
Journal: Modern rheumatology 20080101
Title: Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma.
Journal: Auris, nasus, larynx 20071201
Title: Nafamostat mesilate reversibly blocks acid-sensing ion channel currents.
Journal: Biochemical and biophysical research communications 20071109
Title: Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.
Journal: Intensive care medicine 20070901
Title: Treatment strategy against infection: clinical outcome of continuous regional arterial infusion, enteral nutrition, and surgery in severe acute pancreatitis.
Journal: Journal of gastroenterology 20070801
Title: Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage.
Journal: Interactive cardiovascular and thoracic surgery 20070601
Title: [Uremic pericarditis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20070528
Title: Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Journal: Cancer 20070515
Title: Nafamostat mesilate inhibits high-mobility group box 1 by lipopolysaccharide stimulation in murine macrophage RAW 264.7.
Journal: Shock (Augusta, Ga.) 20070401
Title: Nafamostat is hydrolysed by human liver cytosolic long-chain acyl-CoA hydrolase.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20070301
Title: Low-volume continuous hemodiafiltration with nafamostat mesilate increases trypsin clearance without decreasing plasma trypsin concentration in severe acute pancreatitis.
Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992) 20070101
Title: Nafamostat mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Journal: Journal of anesthesia 20070101
Title: Aprotinin and nafamostat mesilate in liver surgery: effect on blood loss.
Journal: Digestive surgery 20070101
Title: Selection of anticoagulants for leukocytapheresis therapy in cases of active ulcerative colitis.
Journal: Blood purification 20070101
Title: Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2.
Journal: Digestion 20070101
Title: Protective effects of nafamostat mesilate on liver injury induced by lipopolysaccharide in rats: possible involvement of CD14 and TLR-4 downregulation on Kupffer cells.
Journal: Digestive diseases and sciences 20061101
Title: Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
Journal: Scandinavian journal of gastroenterology 20060801
Title: Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma.
Journal: The Journal of allergy and clinical immunology 20060701
Title: [Prostasin].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20060701
Title: Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Journal: International journal of pharmaceutics 20060511
Title: Complement activation is involved in biological responses to leukocyte adsorptive apheresis.
Journal: Digestive diseases and sciences 20060501
Title: [Postoperative acute pulmonary thromboembolism treated with nafamostat mesilate].
Journal: Masui. The Japanese journal of anesthesiology 20060501
Title: Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation.
Journal: Xenotransplantation 20060501
Title: Nafamostat attenuated the impairment of fibrinolysis in animal sepsis model by suppressing the increase of plasminogen activator inhibitor type 1.
Journal: The Journal of trauma 20060401
Title: Involvement of human blood arylesterases and liver microsomal carboxylesterases in nafamostat hydrolysis.
Journal: Drug metabolism and pharmacokinetics 20060401
Title: Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20060201
Title: Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice.
Journal: European journal of pharmacology 20060113
Title: Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20060101
Title: [Quality of life in surgical treatment of pancreatic cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20060101
Title: The role of a protease inhibitor against hepatectomy.
Journal: Hepato-gastroenterology 20060101
Title: Effects of nafamostat mesilate on ADP-induced platelet aggregation and disaggregation in hemodialysis patients.
Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992) 20060101
Title: Involvement of neutrophil recruitment and protease-activated receptor 2 activation in the induction of IL-18 in mice.
Journal: Journal of leukocyte biology 20051101
Title: Effect of intraportal infusion to improve small for size graft injury in living donor adult liver transplantation.
Journal: Transplant international : official journal of the European Society for Organ Transplantation 20050801
Title: Nafamostat mesilate induces production of interleukin-12 and -18 in human peripheral blood mononuclear cells.
Journal: Journal of pharmacological sciences 20050801
Title: Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners.
Journal: Journal of pharmacological sciences 20050801
Title: Small volume resuscitation with hypertonic saline is more effective in ameliorating trauma-hemorrhagic shock-induced lung injury, neutrophil activation and red blood cell dysfunction than pancreatitic protease inhibition.
Journal: The Journal of trauma 20050801
Title: Open heart surgery in a patient with paroxysmal nocturnal hemoglobinuria.
Journal: The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20050601
Title: Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis.
Journal: Pancreas 20050401
Title: Correlation between serum nafamostat mesilate and activated coagulation time during continuous hemodiafiltration.
Journal: Artificial organs 20050401
Title: Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation.
Journal: The Annals of thoracic surgery 20050401
Title: [A patient with Vibrio vulnificus meningoencephalitis].
Journal: Rinsho shinkeigaku = Clinical neurology 20050101
Title: A case of heparin-induced thrombocytopenia with sepsis and congestive heart failure--first autopsy report on Japan--.
Journal: Circulation journal : official journal of the Japanese Circulation Society 20041201
Title: A serine protease inhibitor, nafamostat mesilate, suppresses aldosterone secretions in vivo.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension 20041201
Title: Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanchnic arterial occlusion and reperfusion.
Journal: Shock (Augusta, Ga.) 20041101
Title: [Treatment of acute pancreatitis with protease inhibitor, H2 receptor antagonist and somatostatin analogue].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20041101
Title: [Continuous regional arterial infusion of protease inhibitor and antibiotic for severe acute pancreatitis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20041101
Title: [Role of pancreatic enzymes in gut injury secondary to trauma/hemorrhagic shock in rats].
Journal: Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20041001
Title: Continuous hemodiafiltration in pediatric critical care patients.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20041001
Title: Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts.
Journal: Human reproduction (Oxford, England) 20040901
Title: Intraoperative management of a congenital antithrombin deficient patient on chronic hemodialysis.
Journal: Thrombosis and haemostasis 20040701
Title: [Blood purification for patients with chronic renal failure accompanied by severe liver disease].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040601
Title: [Treatment of uremic patients with high bleeding risk].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040601
Title: [Heparin-induced thrombocytopenia in patients on hemodialysis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040601
Title: [Pregnancy and delivery in patients with hemodialysis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040601
Title: Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft.
Journal: Transplantation 20040527
Title: Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit.
Journal: Pancreas 20040501
Title: [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040501
Title: [How to use anticoagulants in hemodialysis therapy].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040501
Title: [Anticoagulation for plasmapheresis].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040501
Title: [Anticoagulant].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040501
Title: [Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].
Journal: Journal of cardiology 20040401
Title: Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock.
Journal: The Journal of trauma 20040301
Title: Transporter-mediated renal handling of nafamostat mesilate.
Journal: Journal of pharmaceutical sciences 20040201
Title: Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Journal: The Annals of thoracic surgery 20040201
Title: Detection of specific IgE antibodies to nafamostat mesilate as an indication of possible adverse effects of leukocytapheresis using nafamostat mesilate as anticoagulant.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20040201
Title: IL-15 levels in patients with acute hepatic failure.
Journal: Research communications in molecular pathology and pharmacology 20040101
Title: Pharmacokinetics of nafamostat mesilate during continuous hemodiafiltration with a polyacrylonitrile membrane.
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 20031001
Title: Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages.
Journal: International immunopharmacology 20030901
Title: Involvement of proteinase-activated receptor-2 in mast cell tryptase-induced barrier dysfunction in bovine aortic endothelial cells.
Journal: Cellular signalling 20030801
Title: Nafamostat mesilate is an extremely potent inhibitor of human tryptase.
Journal: Journal of pharmacological sciences 20030801
Title: Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient.
Journal: Clinical nephrology 20030601
Title: Successful adult ABO-incompatible liver transplantation: therapeutic strategy for thrombotic microangiopathy is the key to success.
Journal: Transplantation 20030515
Title: Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shock-induced gut and lung injury.
Journal: Shock (Augusta, Ga.) 20030501
Title: Influence of heparin dosage on hemostasis under combined use of Nafamostat mesilate during deep hypothermic circulatory arrest.
Journal: The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20030501
Title: Changes in blood viscosity with synthetic protease inhibitors.
Journal: Journal of pharmacological sciences 20030401
Title: A potent tryptase inhibitor nafamostat mesilate dramatically suppressed pulmonary dysfunction induced in rats by a radiographic contrast medium.
Journal: British journal of pharmacology 20030301
Title: Inhibition of prostasin secretion by serine protease inhibitors in the kidney.
Journal: Journal of the American Society of Nephrology : JASN 20030101
Title: In vitro relationship between the blood nafamostat concentration and activated coagulation time.
Journal: Canadian journal of anaesthesia = Journal canadien d'anesthesie 20030101
Title: Severe abdominal pain associated with allergic reaction to nafamostat mesilate in a chronic hemodialysis patient.
Journal: Internal medicine (Tokyo, Japan) 20021001
Title: Extracorporeal membrane oxygenation with nafamostat mesilate as an anticoagulant for massive pulmonary hemorrhage after living-donor lobar lung transplantation.
Journal: The Journal of thoracic and cardiovascular surgery 20020901
Title: [A case with severe acute pancreatitis treated by regional arterial infusion of nafamostat mesilate and imipenem via both celiac artery and superior mesenteric artery].
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20020901
Title: Two-dimensional analysis of myocardial protein expression following myocardial ischemia and reperfusion in rabbits.
Journal: Proteomics 20020801
Title: [Management of intraoperative anticoagulantless CHD with EVAL-dialyzer in four patients on maintenance hemodialysis].
Journal: Masui. The Japanese journal of anesthesiology 20020301
Title: Case of a bleeding pseudoaneurysm of the middle colic artery complicating acute pancreatitis.
Journal: Hepato-gastroenterology 20020101
Title: Inhibition of natural killer cytotoxicity in vitro by clinical grade serine protease inhibitors.
Journal: Haematologia 20020101
Title: Induction of IkappaB-kinase by cholecystokinin is mediated by trypsinogen activation in rat pancreatic lobules.
Journal: Digestion 20020101
Title: [A case of pancreatic ascites due to rupture of pancreatic pseudocyst successfully treated with continuous arterial infusion of nafamostat mesilate].
Journal: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20011101
Title: Can nafamostat mesilate be used for temporary management of hemodialysis in a patient with heparin-induced thrombocytopenia (HIT)?
Journal: Thrombosis and haemostasis 20011001
Title: [Molecular specificity of nafamostat mesilate (FUT), a drug used for the treatments of DIC and acute pancreatitis and as an anticoagulant--the pharmacodynamics and pharmacological action].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy 20010901
Title: Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
Journal: Anti-cancer drugs 20010901
Title: Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Journal: Surgery 20010801
Title: [Anti-bleeding effect of nafamostat mesilate for the surgery of thoracic ascending aorta].
Journal: Kyobu geka. The Japanese journal of thoracic surgery 20010801
Title: Successful treatment of severe acute pancreatitis by the combination therapy of continuous arterial infusion of a protease inhibitor and continuous hemofiltration.
Journal: Journal of gastroenterology and hepatology 20010801
Title: Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
Journal: Stroke 20010701
Title: The efficacy of nafamostat mesilate on the performance of a hybrid-artificial liver using a polyurethane foam/porcine hepatocyte spheroid culture system in human plasma.
Journal: The International journal of artificial organs 20010101
Title: Attenuation of hepatic ischemia and reperfusion injury by serine protease inhibitor, FUT-175, in dogs.
Journal: Transplantation proceedings 20010101
Title: Site-specific therapeutic effects of protease inhibitors: effect of route of administration in experimental pancreatitis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20010101
Title: Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20010101
Title: Benefit of continuous regional arterial infusion of protease inhibitor and antibiotic in the management of acute necrotizing pancreatitis.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 20010101
Title: A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate.
Journal: British journal of anaesthesia 19990901
Title: Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol.
Journal: British journal of anaesthesia 19981201
Title: Mechanisms of the hyperkalaemia caused by nafamostat mesilate: effects of its two metabolites on Na+ and K+ transport properties in the rabbit cortical collecting duct.
Journal: British journal of pharmacology 19940101
Title: Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
Journal: Internal medicine (Tokyo, Japan) 19921101
Title: [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Journal: Rinsho shinkeigaku = Clinical neurology 19910101
Title: Ikehara S, et al. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice. Immunology. 1985 Aug;55(4):595-600.
Title: Homma S, et al. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells. Int Immunopharmacol. 2018 Jan;54:39-45.
Title: Pak K, et al. Effectiveness of FUT-175, protease inhibitor, as an anticoagulant to hemodialysis. Hinyokika Kiyo. 1988 Jun;34(6):1077-81.
Title: Markus Hoffmann, et al. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 Jun; 64(6): e00754-20.
